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Wednesday, March 4, 2009 677afluorescence complementation (BiFC, Hu, Mol. Cell, 9, 789, 2002) and fluores-
cence correlation spectroscopy (FCS), we have specifically monitored the dif-
fusion of homo-oligomers of three members of the adenosine receptor family of
GPCRs (the A1-, A2A- and A3-adenosine receptors (Ax-AR)) in microdomains
of living cells. This approach has allowed us to directly investigate the mem-
brane organisation of homo-oligomeric forms of these receptors.
FCS measurements were carried out as previously described (Briddon, PNAS,
101, 4673, 2004).on the upper cell membrane of CHO-K1 cells transiently ex-
pressing C-terminal fusions of each AR subtype with either wtYFP (represent-
ing total receptor population) or C-YFP and N-YFP (representing oligomeric
receptors).
Homo-oligomers of all three subtypes were detected and showed a high degree
of membrane localisation. For all three subtypes, receptors labelled with wtYFP
(total receptor population) showed similar diffusion co-efficients (D¼0.40,
0.51 and 0.43 mm2/s for A1-, A2A- and A3-AR, respectively). The oligomeric
A3-AR (measured using BiFC) had a significantly faster diffusion co-efficient
when compared to the A3-AR total population (D¼0.60 vs. 0.43 mm2/s,
P<0.05) suggesting that the homo-oligomeric A3-AR represents a faster diffus-
ing fraction of the total receptor population. This was not the case for the A1-
and A2A-ARs. Further investigation into the extent of receptor dimerisation for
each ARs subtype among the total population and their membrane mobilities
was carried out using photon counting histogram (PCH) analysis and fluores-
cence recovery after photobleaching (FRAP). These data indicate important
differences in the molecular organisation of the monomeric vs oligomeric
forms of the A3-AR, and also differences among receptor subtypes in their pro-
pensity for dimer formation.
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The aim of this study was to investigate the association and dissociation kinet-
ics of fluorescently labelled adenosine ligands at the human adenosine A3 re-
ceptor at a single cell level. CHO cells stably expressing the human adenosine
A3 receptor were exposed to 100 nM of fluorescent ligand after which cells
were washed with buffer alone or in the presence of an unlabelled adenosine
ligand. Confocal fluorescence and phase images were obtained using a Zeiss
510 confocal microscope.
The association of ABA-X-BY630, a novel N6-aminoalkyl derivative of aden-
osine which incorporates the BODIPY [630/650] fluorophore, was monophasic
with an association rate constant, kon, of 574700 5 19000 M
1sec1, n¼7.
ABA-X-BY630 dissociation was determined under conditions reflecting that
of infinite dilution in the absence and presence of the selective adenosine A3
antagonist, MRS 1220. Under both conditions, ABA-X-BY630 dissociation
was monophasic, however the dissociation rate in the absence of antagonist
(koff ¼ 0.019 5 0.001 sec1, n¼4) was significantly slower than that in the
presence of 1 mM MRS 1220 (koff ¼ 0.0805 0.007 sec1, n¼4).
In summary, confocal imaging has been used to directly measure, at single cell
level, the binding kinetics of the fluorescent adenosine agonist, ABA-X-
BY630. In addition, the perfusion system allows for the rapid removal of ligand
and as such the comparison of ABA-X-BY630 dissociation in the absence and
presence of antagonist. Under infinite dilution conditions, the dissociate rate of
ABA-X-BY630 should be unaffected by the presence of a simple competitive
antagonist. Therefore the ability of MRS 1220 to enhance the dissociation rate
of ABA-X-BY630 suggests that there may be a negatively cooperative interac-
tion occurring between the two ligands. Similar experiments have also been
performed using additional fluorescently labelled adenosine ligands.
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Human peripheral cannabinoid receptor CB2 expressed in E. coli. has been pu-
rified, and successfully reconstituted in functional form into lipid bilayers com-
posed of phosphatidylcholine, phosphatidylserine, and cholesteryl hemisucci-
nate (CHS). The reconstitution was carried out by detergent removal from
the CB2-lipid-detergent mixed micelles on an adsorbent column, or by rapid
dilution below the critical micelle concentration followed by washing on a con-
centrator. Proteoliposomes prepared at the CB2:phospholipid molar ratio of
1:600 showed the following basic physical properties: Free of detergents (as an-
alyzed by high-resolution 1H NMR), homogeneity of the CB2-to-lipid ratio
over the proteoliposome particles (by sucrose gradient centrifugation), unila-
mellarity with a mean diameter of ~150-200 nm (by dynamic light scattering),and functional integrity (by G-protein activation assay). Using the proteolipo-
somes, CB2-lipid interactions were investigated by solid-state NMR. Order pa-
rameters of the phospholipid acyl chains measured by 2H quadrupolar splittings
indicated that CHS, a detergent-soluble analog of cholesterol, preferentially in-
teracts with the 1-palmitoyl-2-oleoyl-sn-glycero-3-phospholipids over CB2. By
probing 1H NMR saturation transfer, evidence for CB2-lipid interactions at the
lipid acyl chains and less significant interactions at the glycerol backbone and
the headgroups were observed. 1H spin-lattice relaxation rates decreased nota-
bly at the acyl-chains upon CB2 incorporation, indicating reduced motion on
the nanosecond timescale corresponding to the restriction of phospholipid wob-
bling about the bilayer normal. Structure-function relationships in view of the
role of interactions between CB2 and anionic phosphatidylserine in activation
of G-protein will also be discussed.
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Like several other members of the G-protein coupled receptor (GPCR) family,
opioid receptors interact among themselves at the plasma membrane to form
dimers/oligomers. Despite recent compelling evidence for the involvement of
transmembrane (TM) regions at the dimerization/oligomerization interface of
GPCRs, the specific residues in contact are unknown for most receptors, includ-
ing the opioid receptor subtypes. Based on prior inferences from correlated mu-
tation analysis, we performed experimental testing of the interfaces of delta-
(DOR) and mu- (MOR) opioid receptor oligomers by carrying out cross-linking
studies on a series of substituted cysteines in TM1, 4 and 5. Strong cross-link-
ing was observed by copper phenanthroline (CuP) (1:3mM) at position 4.58 in
both DOR andMOR, and cross-linking, albeit less extensive, was also observed
at 1.36 and 5.38, consistent with the involvement of these helices at inter-pro-
tomer interfaces in the dopamine D2 receptor. We used these experimental data
to guide the construction of initial configurations of DOR and MOR homo-
dimers in an explicit dipalmitoyl phosphatidyl choline (DPPC)-cholesterol-wa-
ter environment. The TM regions of the individual protomers were built by ho-
mology modeling using the recent beta2 adrenergic receptor crystal structure as
a template, while the loop regions were built using the fragment-based loop-
modeling protocol of Rosetta. To explore the energetics and dynamics of the
proposed homodimerization interfaces, we carried out metadynamics analyses
of the DOR and MOR homodimers using collective variables that describe the
relative position of the interacting protomers. The results provide new insights
into the relative stability of opioid receptor dimers, and suggest specific resi-
dues and interactions that are responsible for the gain and/or loss in binding af-
finity. Given the robust bioluminescence resonance energy transfer (BRET) we
observe in experiments with DOR and MOR homo- and heteromers, these pre-
dictions can be readily tested.
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Many G protein coupled receptors have been described to assemble as dimers
or higher order oligomers but their existence and functional relevance is still
a matter of controversy. Based on current techniques stability, extent and
size of complexes of these receptors is difficult to determine. Therefore, we
took advantage of a novel generally applicable approach based on dual-color
fluorescence recovery after photobleaching (FRAP) microscopy to analyze sta-
bility and extent of di- and oligomerization of membrane proteins. Extracellu-
larly YFP-labeled receptors were immobilized with a polyclonal antibody di-
rected against YFP. Then, changes in the lateral mobility of coexpressed
intracellularly CFP-tagged receptors were studied and served as readout for re-
ceptor interactions. In order to allow for comparison with theoretically calcu-
lated effects relative expression ratios of intracellularly and extracellularly
tagged receptors were carefully determined using a reference construct.
We established this approach with monomeric (CD86) and covalent dimeric
(CD28) proteins, which have been previously characterized. CD86 was fully
mobile indicating to exist as a monomeric entity. For CD28 we detected a re-
striction which was dependent on the relative expression ratio of receptors with
an intracellular and an extracellular label. This restriction was in good agree-
ment with theoretically calculated recoveries for dimers. Using this novel ap-
proach to investigate homo-interactions between beta-adrenergic receptors
(beta-AR) we discovered previously unknown differences between beta1-
